AXIOMER

Serial Number 79192823
Registration 5229979
709

Registration Progress

Application Filed
Mar 23, 2016
Under Examination
Approved for Publication
Jan 10, 2017
Published for Opposition
Jan 10, 2017
Registered
Jun 27, 2017

Trademark Image

AXIOMER

Basic Information

Serial Number
79192823
Registration Number
5229979
Filing Date
March 23, 2016
Registration Date
June 27, 2017
Published for Opposition
January 10, 2017
Cancellation Date
January 12, 2024
Drawing Code
5

Status Summary

Current Status
Inactive
Status Code
709
Status Date
Jan 12, 2024
Classes
042

Rights Holder

ProQR Therapeutics II B.V.

99
Address
Zernikedreef 9
NL-2333 CK Leiden
NL

Ownership History

ProQR Therapeutics II B.V.

Original Applicant
99
NL

ProQR Therapeutics II B.V.

Owner at Publication
99
NL

ProQR Therapeutics II B.V.

Original Registrant
99
NL

Legal Representation

Attorney
Krista Weber Powell

USPTO Deadlines

Next Deadline
609 days remaining
Section 8 & 9 (10-Year) Renewal Due (Based on registration date 2017-06-27)
Due Date
June 27, 2027
Grace Period Ends
December 27, 2027

Application History

36 events
Date Code Type Description Documents
Oct 7, 2024 INNT P TOTAL INVALIDATION PROCESSED BY THE IB Loading...
Sep 14, 2024 INPC P INVALIDATION PROCESSED Loading...
Sep 14, 2024 INTS P TOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB Loading...
Sep 13, 2024 INTR P TOTAL INVALIDATION OF REG EXT PROTECTION CREATED Loading...
Jan 12, 2024 C71T O CANCELLED SECTION 71 Loading...
Jun 27, 2022 REM3 E COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED Loading...
Apr 12, 2018 INNA R INVALIDATION REVIEWED - NO ACTION REQUIRED BY OFFICE Loading...
Apr 8, 2018 INPR P PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED Loading...
Oct 28, 2017 FINO P FINAL DECISION TRANSACTION PROCESSED BY IB Loading...
Sep 28, 2017 FICS P FINAL DISPOSITION NOTICE SENT TO IB Loading...
Sep 28, 2017 FIMP P FINAL DISPOSITION PROCESSED Loading...
Sep 27, 2017 FICR P FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB Loading...
Aug 8, 2017 LIME I LIMITATION FROM THE IB EXAMINED AND ENTERED Loading...
Aug 8, 2017 COC. O CORRECTION UNDER SECTION 7 - PROCESSED Loading...
Aug 8, 2017 APRE A CASE ASSIGNED TO POST REGISTRATION PARALEGAL Loading...
Jun 27, 2017 R.PR A REGISTERED-PRINCIPAL REGISTER Loading...
Jun 23, 2017 LIMG M LIMITATION OF GOODS RECEIVED FROM IB Loading...
May 24, 2017 ETOP T EXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED Loading...
Apr 20, 2017 ADCH M CHANGE OF NAME/ADDRESS REC'D FROM IB Loading...
Feb 6, 2017 ETOF T EXTENSION OF TIME TO OPPOSE RECEIVED Loading...
Jan 10, 2017 PUBO A PUBLISHED FOR OPPOSITION Loading...
Jan 10, 2017 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Dec 21, 2016 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
Dec 2, 2016 CNSA O APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Dec 1, 2016 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED Loading...
Dec 1, 2016 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
Dec 1, 2016 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED Loading...
Nov 11, 2016 RFNT P REFUSAL PROCESSED BY IB Loading...
Oct 27, 2016 RFCS P NON-FINAL ACTION MAILED - REFUSAL SENT TO IB Loading...
Oct 27, 2016 RFRR P REFUSAL PROCESSED BY MPU Loading...
Oct 11, 2016 MAFR O APPLICATION FILING RECEIPT MAILED Loading...
Oct 7, 2016 RFCR E NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW Loading...
Oct 6, 2016 CNRT R NON-FINAL ACTION WRITTEN Loading...
Oct 6, 2016 DOCK D ASSIGNED TO EXAMINER Loading...
Oct 6, 2016 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Oct 1, 2016 REPR M SN ASSIGNED FOR SECT 66A APPL FROM IB Loading...

Detailed Classifications

Class 042
[ Laboratory research services relating to pharmaceuticals; medical research; pharmaceutical research and development; laboratory research and analysis in the field of medicines; services of biotechnological, chemical and pharmacological laboratories, including scientific and technological research, in relation to the production of chemicals and biotechnological products for use in the preparation of pharmaceuticals; development of pharmaceutical preparations and medicines; development of technologies for the production of pharmaceutical semi finished and/or finished preparations; academic research, medical and biochemical research and development services; chemistry, laboratory technicians' and engineering services; research and development in the field of biotechnology; research into and development and testing of pharmaceutical and biochemical semi- finished products, in particular for use in medicines, research into and development and testing of medicines; development of test systems for pharmaceutical, medical and sanitizing preparations; services development and identification of and research into new drug targets ]

Additional Information

Color Claim
Color is not claimed as a feature of the mark.
Other
In the heading, Int. Cl. 1 and Int. Cl. 42 should be deleted. In the statement line 5 and lines 10-22, should deleted. In the statement, lines 6-9, should be deleted, except "pharmaceutical preparations for the treatment of genetic diseases based on oligonucleotides, rna". In the statement, line 8, before "rna" "for use in" should be inserted.

Classification

International Classes
042